Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts

Pallavi Madhiraju- September 2, 2024 0

Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson ... Read More

Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection

Pallavi Madhiraju- March 9, 2023 0

Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval for its abbreviated new drug application (ANDA) for Thiamine Hydrochloride Injection USP, ... Read More

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Pallavi Madhiraju- November 28, 2022 0

Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, ... Read More

Fresenius Kabi launches Levothyroxine Sodium Injection Solution in US

pharmanewsdaily- July 8, 2019 0

German pharma company Fresenius Kabi has launched its severe hypothyroidism treatment -Levothyroxine Sodium Injection Solution in 100 mcg per 5 mL, 200 mcg per 5 ... Read More

Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US

pharmanewsdaily- December 10, 2018 0

Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United States, targeting a critical need for pediatric ... Read More

Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options

pharmanewsdaily- November 4, 2018 0

German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of ... Read More